A Look At Exponent (EXPO) Valuation As Earnings Optimism Builds Before February 5 Report

Simply Wall St.

Feb 02

Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2608570898"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608570898\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608570898?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9612012-choice1-main-header/1585186781062","is_english":true,"pubTime":"2026-02-02 17:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608570898","market":"nz","top_or_hot":-1,"title":"A Look At Exponent (EXPO) Valuation As Earnings Optimism Builds Before February 5 Report","media":"Simply Wall St.","content":"<div>\n<p>Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/commercial-services/nasdaq-expo/exponent/news/a-look-at-exponent-expo-valuation-as-earnings-optimism-build\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Exponent (EXPO) Valuation As Earnings Optimism Builds Before February 5 Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Exponent (EXPO) Valuation As Earnings Optimism Builds Before February 5 Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-02 17:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/commercial-services/nasdaq-expo/exponent/news/a-look-at-exponent-expo-valuation-as-earnings-optimism-build><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/commercial-services/nasdaq-expo/exponent/news/a-look-at-exponent-expo-valuation-as-earnings-optimism-build\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EXPO","symbol_name":"毅博科技咨询","start_time":0,"source_url":"https://simplywall.st/stocks/us/commercial-services/nasdaq-expo/exponent/news/a-look-at-exponent-expo-valuation-as-earnings-optimism-build","article_id":"2608570898","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9612012-choice1-main-header/1585186781062"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/commercial-services/nasdaq-expo/exponent/news/a-look-at-exponent-expo-valuation-as-earnings-optimism-build","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2608570898","pubTimestamp":1770023756,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader consensus.\nSee our latest analysis for Exponent.\nExponent’s share price has recently been choppy, with a 7 day share price return of a 4.6% decline, a 30 day share price return of 2.5%, and a current price of US$71.87. Its 1 year total shareholder return shows a 20.5% decline, which points to weaker...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"EXPO":"毅博科技咨询"},"translate_title":"随着2月5日报告发布前盈利乐观情绪的增强，看看指数(EXPO)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EXPO":1.5},"content_text":"Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader consensus. See our latest analysis for Exponent. Exponent’s share price has recently been choppy, with a 7 day share price return of a 4.6% decline, a 30 day share price return of 2.5%, and a current price of US$71.87. Its 1 year total shareholder return shows a 20.5% decline, which points to weaker longer-term momentum. If you are watching how earnings expectations affect specialist service companies like Exponent, this can be a useful moment to broaden your search and check out fast growing stocks with high insider ownership. With EXPO trading at a discount to both some analyst targets and one intrinsic value estimate despite positive revenue and net income growth, you have to ask: is this a buying opportunity, or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 15.9% Undervalued With Exponent’s fair value narrative sitting at $85.50 against a last close of $71.87, the current share price sits well below that central estimate.  The intensifying focus on safety, risk management, and product reliability, especially in emerging fields such as advanced driver assistance systems, battery storage, and wearables, is positioning Exponent as a preferred partner for critical litigation and proactive risk projects, which should help sustain premium pricing and secure net margins as these markets expand.  Read the complete narrative. Curious what kind of revenue profile and profit margins sit behind that $85.50 figure? The narrative leans on steady growth assumptions, firm profitability and a valuation multiple that assumes investor confidence holds up over time. Result: Fair Value of $85.50 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to weigh the risk that slower revenue growth and lower utilization, together with rising automation, could pressure Exponent’s margins and traditional billing model. Find out about the key risks to this Exponent narrative. Another Way To Look At Valuation Our DCF model arrives at a value of $108.02 per share for Exponent, which is higher than both the $85.50 fair value narrative and the current price of $71.87. If you put more weight on cash flows than earnings multiples, that gap might catch your eye. Look into how the SWS DCF model arrives at its fair value. EXPO Discounted Cash Flow as at Feb 2026 Build Your Own Exponent Narrative If parts of this story do not quite fit your view, or you would rather lean on your own work, you can build a custom thesis in minutes with Do it your way. A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Exponent. Looking for more investment ideas? If Exponent has caught your attention, do not stop here. The market is full of other stocks with different risk and return profiles waiting to be researched.  Spot potential value candidates by scanning these 886 undervalued stocks based on cash flows that might line up with your expectations on price and fundamentals. Tap into the theme of artificial intelligence by screening these 24 AI penny stocks that are directly exposed to this area. Hunt for income opportunities with these 12 dividend stocks with yields > 3% that could suit a yield focused approach.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Exponent might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}